XBiotech posts Phase 1 results for Natrunix dose-escalation study in healthy volunteersAug 14Trial updatenatrunixXBiotech, Inc.
XBiotech posts results for XB2001 pancreatic cancer trial, over five years after registrationAug 4Trial updateXB2001XBiotech, Inc.
Sign inSign in